Jain PharmaBiotech, May 2012, Pages: 1037
of ovarian cancer
Concluding remarks on testing for ovarian cancerPancreaticcancer
Prostate cancer
Early detection of prostate cancer recurrence by nanotechnology
Gene expression analysis of prostate
GlobalData, June 2011, Pages: 82
of Gemcitabine plus S-1 versus S-1 versus Gemcitabine in Unresectable Advanced PancreaticCancer in Japan and Taiwan: GEST study
2.6.7 Exposure-response Analysis to Facilitate Phase III Dose Selection for AMG 479
Espicom Business Intelligence Ltd, Nov 2010, Pages: 170
of trends and impacts on companies: assess the winners and losers!
- An assessment of key therapeutic approaches – the rise of biologicals
- Detailed analysis of 21 products that will dominate the cancer
Business Insights, June 2010, Pages: 191
Leukemia diagnostic kit cleared
New lung cancer test
AMD diagnostic
Key biomarker gene
Point of care instrumentation
Genotyping test launch
Innovative colon cancer diagnostic
Innovative pancreatic
Venture Planning Group, Oct 2010, Pages: 1200
The 2011 Cancer Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers The cancer diagnostics market is on the verge of explosion
BioInformant, Jan 2010, Pages: 126
, isolated from umbilical tissue; cancer stem cells, which give rise to a clonal populations of cells that form tumours or disperse in the body; and animal stem cells, which are derived from non-human sources
Life Science Intelligence, Inc., July 2007
-of-care platform technology (CRP & Cyst C) for assessing risk of cardiovascular disease and renal dysfunction
Company 64 - Nanotechnology-based cancer therapy with contactless activation of tumor-specific
Marketstrat Inc, Nov 2009, Pages: 526
, market shares, competitive position maps, market conditions, brands and models, and company profiles. The report provides detailed market estimates and forecasts for GI Devices by product segment, separately
